SpecStream

Data / Form D filings / Conexeu Sciences Inc.

Conexeu Sciences Inc.: Form D filing

Conexeu Sciences Inc., a biotechnology company in Reno, NV, filed a Form D with the SEC in 2026. The latest, on October 21, 2026, reports $1.5 million sold of a $3 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Get filings like this oneWeekly RSS feed

Company details from the filing

Address
50 WEST LIBERTY STREET, SUITE 880, Reno, NV, 89501
Phone
(424) 333-5622
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Nevada
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2066836

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 21New notice$2,999,994$1,499,997$1,499,9972Oct 15sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
DAVID R BOGARTExecutive Officer, Director
MILES HARRISONExecutive Officer, Director
AARON FARBERGDirector
STEPHEN D INOUYEExecutive Officer
CLAUDIA CHAVEZ-MUNOZExecutive Officer
JEFF SHARPEDirector
Z PAUL LORENCDirector
SEBASTIAN PURCELLDirector
BRIAN PILCHERExecutive Officer
ANDREW COSTADirector
APRIL BURKEDirector
ANA BASTIANI-POSNERDirector

Every Form D from the week of Oct 19 · All recent filings in Nevada · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Conexeu Sciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.